Morgan Stanley is to scrap the bonus cap for its London bankers in a post-Brexit shake-up that paves the way for multimillion-pound payouts to top performers.
(Bloomberg) -- Bicara Therapeutics is working with Morgan Stanley on a US initial public offering, people familiar with the situation said, as the market for first-time share sales is showing signs of normalizing. Most Read from BloombergJustice Department to Charge Boeing, Seeks Guilty Plea from PlanemakerBiden Asks Donors to Stay Following Disastrous DebateBiden's Defiance Has Democrats Fearing They'll Lose White HouseTrump as President or Private Citizen: Why Supreme Court’s Immunity Ruling I
NEW YORK, June 28, 2024--Morgan Stanley (NYSE: MS) announced that it will increase its quarterly common stock dividend to $0.925 per share from the current $0.85 per share, beginning with the common stock dividend expected to be declared by the Firm’s Board of Directors in the third quarter of 2024.